EClinical solutions market is estimated to reach 7.61 Billion by 2022

By -

The global eClinical solutions market is estimated to reach 7.61 Billion by 2022, at a CAGR of 12.4% within the forecast period of 2017 to 2022.

(EMAILWIRE.COM, July 26, 2018 ) The adoption of novel software solutions during clinical research and rising government funding to support clinical trials are key factors fueling the growth of the market. Furthermore, increased outsourcing of clinical trial processes by industrial researchers to contract research organizations (CROs) offers growth opportunities for market players.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=553

The electronic data capture (EDC) and clinical data management system (CDMS) segment accounted for the largest share of the global eClinical solutions market in 2016. The electronic clinical outcome assessment (eCOA) segment is expected to achieve the highest CAGR during the forecast period. The increasing demand for eDiaries in clinical studies to collect patient self-reports by major pharmaceutical companies and the use of mobile and digital technologies are driving the growth of this market segment.

Emerging markets including China, South Korea, Taiwan, and India are attractive destinations for outsourcing clinical trials due to the presence of a large patient population and the low operating cost of conducting clinical trials in these countries. Less stringent regulatory guidelines compared to developed nations, shortage of trial volunteers in Europe and North America, and the growing number of life science research companies and CROs are key factors propelling the demand for eClinical solutions in these emerging markets. In order to leverage the high growth opportunities, leading market players are expanding their presence in these nations.

As of 2016, Oracle Corporation (U.S.) held the leadership position in the global eClinical solutions market. Over the past three years, the company has adopted partnerships, agreements, and collaborations and product launches, enhancements, and deployments as key business strategies to ensure its dominance. Medidata Solutions, Inc. (U.S.) PAREXEL International Corporation (U.S.), BioClinica, Inc. (U.S.), CRF Health (U.S.), DATATRAK International, Inc. (U.S.), ERT (U.S.), MaxisIT Inc. (U.S.), Bio-Optronics, Inc. (U.S.), eClinical Solutions, Inc. (U.S.), Merge Healthcare Incorporated (U.S.), and OmniComm Systems, Inc. (U.S.) are some of the other key players in this market.

Target Audience

Healthcare IT Service Providers
eClinical Solution Vendors
Clinical Research Organizations
Pharmaceutical/Biopharmaceutical Companies
Research and Development (R&D) Companies
Business Research and Consulting Service Providers
Medical Research Laboratories
Academic Medical Centers/Universities/Hospitals

Read More: https://www.marketsandmarkets.com/Market-Reports/eclinical-solutions-market-553.html

Read other news from MarketsandMarkets™

Timing Devices Market Size, Share, Revenue Trends & Forecast to 2030

MarketsandMarkets™ - Sep 18, 2023
Timing Devices Market by Type (Oscillators, Atomic Clocks, Clock Generators, Clock Buffers, Jitter Attenuators), Material (Crystal, Silicon, Ceramic), Vertical (Consumer Electronics, Automotive) and Region - Global Forecast to 2030 ...Read more

Artificial Intelligence Market Segmented by Product, Top Manufacturers, Geography Trends & Growth Opportunity to 2030

MarketsandMarkets™ - Sep 18, 2023
Artificial Intelligence technology such as machine learning, natural language processing, computer vision, and others are revolutionizing various sectors, including healthcare, finance, manufacturing, and retail. ...Read more

Digital PCR (dPCR) and Real-time PCR (qPCR) Market worth $12.4 billion by 2028, at a CAGR of 7.8%.

MarketsandMarkets™ - Sep 18, 2023
"Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product (Instruments, Reagents & Consumables, Software & Services), Application (Clinical, Research, Forensic), End User (Hospital, Diagnostic Labs, Pharma, Biotech, CROs) - Global Forecast to 2028". ...Read more